These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

281 related items for PubMed ID: 19773725

  • 1. Proteinuria in the prognosis of IgA nephropathy.
    Aucella F, Netti GS, Piemontese M, Cincione IR, Infante B, Gesualdo L.
    Minerva Urol Nefrol; 2009 Sep; 61(3):235-48. PubMed ID: 19773725
    [Abstract] [Full Text] [Related]

  • 2. High urinary excretion of kidney injury molecule-1 is an independent predictor of end-stage renal disease in patients with IgA nephropathy.
    Peters HP, Waanders F, Meijer E, van den Brand J, Steenbergen EJ, van Goor H, Wetzels JF.
    Nephrol Dial Transplant; 2011 Nov; 26(11):3581-8. PubMed ID: 21467131
    [Abstract] [Full Text] [Related]

  • 3. Effect of hematuria on the outcome of IgA nephropathy with mild proteinuria.
    Tanaka K, Moriyama T, Iwasaki C, Takei T, Nitta K.
    Clin Exp Nephrol; 2015 Oct; 19(5):815-21. PubMed ID: 25475403
    [Abstract] [Full Text] [Related]

  • 4. The product of duration and amount of proteinuria (proteinuria index) is a possible marker for glomerular and tubulointerstitial damage in IgA nephropathy.
    Eiro M, Katoh T, Kuriki M, Asano K, Watanabe K, Watanabe T.
    Nephron; 2002 Apr; 90(4):432-41. PubMed ID: 11961402
    [Abstract] [Full Text] [Related]

  • 5. Factors predicting progression of IgA nephropathies.
    Coppo R, D'Amico G.
    J Nephrol; 2005 Apr; 18(5):503-12. PubMed ID: 16299675
    [Abstract] [Full Text] [Related]

  • 6. Significance of clinical and morphological prognostic risk factors in IgA nephropathy: follow-up study of comparison patient groups with and without renoprotection.
    Riispere Ž, Kuudeberg A, Seppet E, Sepp K, Ilmoja M, Luman M, Kõlvald K, Auerbach A, Ots-Rosenberg M.
    BMC Nephrol; 2017 Mar 14; 18(1):89. PubMed ID: 28292274
    [Abstract] [Full Text] [Related]

  • 7. Long-term outcome of childhood IgA nephropathy with minimal proteinuria.
    Higa A, Shima Y, Hama T, Sato M, Mukaiyama H, Togawa H, Tanaka R, Nozu K, Sako M, Iijima K, Nakanishi K, Yoshikawa N.
    Pediatr Nephrol; 2015 Dec 14; 30(12):2121-7. PubMed ID: 26238276
    [Abstract] [Full Text] [Related]

  • 8. Clinicopathological Features to Predict Progression of IgA Nephropathy with Mild Proteinuria.
    Chen D, Liu J, Duan S, Chen P, Tang L, Zhang L, Feng Z, Cai G, Wu J, Chen X.
    Kidney Blood Press Res; 2018 Dec 14; 43(2):318-328. PubMed ID: 29529608
    [Abstract] [Full Text] [Related]

  • 9. Clinicopathological features and outcomes of IgA nephropathy with hematuria and/or minimal proteinuria.
    Tan M, Li W, Zou G, Zhang C, Fang J.
    Kidney Blood Press Res; 2015 Dec 14; 40(2):200-6. PubMed ID: 25924707
    [Abstract] [Full Text] [Related]

  • 10. The retrospective analysis of 343 Czech patients with IgA nephropathy--one centre experience.
    Maixnerova D, Bauerova L, Skibova J, Rysava R, Reiterova J, Merta M, Honsova E, Tesar V.
    Nephrol Dial Transplant; 2012 Apr 14; 27(4):1492-8. PubMed ID: 21891776
    [Abstract] [Full Text] [Related]

  • 11. [Clinical and pathological analysis of IgA nephropathy with acute kidney injury].
    Chen MG, Ye XH, Liang HY, Yang Q.
    Zhonghua Er Ke Za Zhi; 2016 Aug 14; 54(8):610-3. PubMed ID: 27510875
    [Abstract] [Full Text] [Related]

  • 12. Clinical features and natural history of IgA nephropathy.
    Rychlik I, Andrassy K, Waldherr R, Zuna I, Tesar V, Jancová E, Stejskalová A, Ritz E.
    Ann Med Interne (Paris); 1999 Feb 14; 150(2):117-26. PubMed ID: 10392260
    [Abstract] [Full Text] [Related]

  • 13. Randomized controlled clinical trial of corticosteroids plus ACE-inhibitors with long-term follow-up in proteinuric IgA nephropathy.
    Manno C, Torres DD, Rossini M, Pesce F, Schena FP.
    Nephrol Dial Transplant; 2009 Dec 14; 24(12):3694-701. PubMed ID: 19628647
    [Abstract] [Full Text] [Related]

  • 14. [The effects of angiotensin-converting enzyme inhibitor on IgA nephropathy and the influencing factors].
    Shi X, Chen X, Liu S, Zhuang Y, Zhang Y.
    Zhonghua Nei Ke Za Zhi; 2002 Jun 14; 41(6):399-403. PubMed ID: 12137603
    [Abstract] [Full Text] [Related]

  • 15. Prospective trial of combined therapy with heparin/warfarin and renin-angiotensin system inhibitors in progressive IgA nephropathy.
    Ishii T, Kawamura T, Tsuboi N, Ogura M, Utsunomiya Y, Hosoya T.
    Contrib Nephrol; 2007 Jun 14; 157():114-9. PubMed ID: 17495447
    [Abstract] [Full Text] [Related]

  • 16. Long-term renal survival and related risk factors in patients with IgA nephropathy: results from a cohort of 1155 cases in a Chinese adult population.
    Le W, Liang S, Hu Y, Deng K, Bao H, Zeng C, Liu Z.
    Nephrol Dial Transplant; 2012 Apr 14; 27(4):1479-85. PubMed ID: 21965586
    [Abstract] [Full Text] [Related]

  • 17. Remission of proteinuria improves prognosis in IgA nephropathy.
    Reich HN, Troyanov S, Scholey JW, Cattran DC, Toronto Glomerulonephritis Registry.
    J Am Soc Nephrol; 2007 Dec 14; 18(12):3177-83. PubMed ID: 17978307
    [Abstract] [Full Text] [Related]

  • 18. High serum IgA/C3 ratio better predicts a diagnosis of IgA nephropathy among primary glomerular nephropathy patients with proteinuria ≤ 1 g/d: an observational cross-sectional study.
    Gong WY, Liu M, Luo D, Liu FN, Yin LH, Li YQ, Zhang J, Peng H.
    BMC Nephrol; 2019 Apr 30; 20(1):150. PubMed ID: 31039758
    [Abstract] [Full Text] [Related]

  • 19. Treatment of IgA nephropathy.
    Pozzi C.
    J Nephrol; 2016 Feb 30; 29(1):21-5. PubMed ID: 26577268
    [Abstract] [Full Text] [Related]

  • 20. Urinary excretion of low-molecular-weight proteins as prognostic markers in IgA nephropathy.
    Peters HP, van den Brand JA, Wetzels JF.
    Neth J Med; 2009 Feb 30; 67(2):54-61. PubMed ID: 19299847
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.